Literature DB >> 3019353

Studies on several pyrrolo[2,3-d]pyrimidine analogues of adenosine which lack significant agonist activity at A1 and A2 receptors but have potent pharmacological activity in vivo.

L P Davies, J Baird-Lambert, J F Marwood.   

Abstract

5'-Deoxy-5-iodotubercidin was previously reported to cause potent muscle relaxation and hypothermia when injected i.p. into mice. In normotensive rats, i.v. injection reduced blood pressure and heart rate. 5-Iodotubercidin possessed the same in vivo activities whereas tubercidin was pharmacologically almost inactive. None of these compounds interacted significantly with Al adenosine receptors, as determined by their ability to displace 3H-N6-phenylisopropyladenosine or 3H-5'-N-ethylcarboxamidoadenosine bound to rat brain membranes. Furthermore these compounds were much weaker than adenosine as agonists of adenosine-stimulated adenylate cyclase in guinea-pig brain slices (A2 receptors). A previous report showed that 5'-deoxy-5-iodotubercidin and 5-iodotubercidin were very potent inhibitors of adenosine kinase from rat or guinea-pig brain and were potent inhibitors of 3H-adenosine uptake into brain slices; relative to the halogenated derivatives, tubercidin was quite weak as an inhibitor of adenosine kinase and of adenosine uptake. We therefore propose that a significant part of the in vivo activity of the two halogenated tubercidin analogues may not be due to a direct agonist action at A1 and/or A2 adenosine sites (as proposed for a number of other metabolically-stable analogues of adenosine) but may result from an inhibition of reuptake of endogenously-released adenosine; the increased extracellular levels of adenosine resulting from this action could then interact directly with membrane receptors. Consistent with this, low concentrations of 5'-deoxy-5-iodotubercidin were shown to significantly potentiate the effects of exogenous adenosine on blood pressure and heart rate in anaesthetized rats and on adenosine-stimulated cAMP generation in guinea-pig brain slices. None of these compounds interacted with central benzodiazepine receptors. The cardiovascular and behavioural effects of 5'-deoxy-5-iodotubercidin and 5-iodotubercidin were blocked by theophylline; results from the cardiovascular studies suggest there may be different adenosine receptors in heart and blood vessels.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3019353     DOI: 10.1016/0006-2952(86)90381-3

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  8 in total

1.  Profound hypothermia after adenosine kinase inhibition in A1AR-deficient mice suggests a receptor-independent effect of intracellular adenosine.

Authors:  Christoph Eisner; SooMi Kim; Alexandra Grill; Yan Qin; Marion Hoerl; Josephine Briggs; Hayo Castrop; Manfred Thiel; Jurgen Schnermann
Journal:  Pflugers Arch       Date:  2016-12-14       Impact factor: 3.657

2.  Inhibition of adenosine kinase by phosphonate and bisphosphonate derivatives.

Authors:  Jae Park; Bhag Singh; Radhey S Gupta
Journal:  Mol Cell Biochem       Date:  2006-02       Impact factor: 3.396

3.  Identification of the glycogenic compound 5-iodotubercidin as a general protein kinase inhibitor.

Authors:  D Massillon; W Stalmans; G van de Werve; M Bollen
Journal:  Biochem J       Date:  1994-04-01       Impact factor: 3.857

4.  Adenosine actions are preserved in corpus cavernosum from obese and type II diabetic db/db mouse.

Authors:  Fernando Silva Carneiro; Fernanda R C Giachini; Victor V Lima; Zidonia N Carneiro; Romulo Leite; Edward W Inscho; Rita C Tostes; R Clinton Webb
Journal:  J Sex Med       Date:  2008-01-21       Impact factor: 3.802

5.  Modulation of excitatory synaptic transmission by adenosine released from single hippocampal pyramidal neurons.

Authors:  J M Brundege; T V Dunwiddie
Journal:  J Neurosci       Date:  1996-09-15       Impact factor: 6.167

6.  Stimulation of rat liver glycogen synthesis by the adenosine kinase inhibitor 5-iodotubercidin.

Authors:  R E Flückiger-Isler; P Walter
Journal:  Biochem J       Date:  1993-05-15       Impact factor: 3.857

Review 7.  Pyrrolo[2,3-d]pyrimidine (7-deazapurine) as a privileged scaffold in design of antitumor and antiviral nucleosides.

Authors:  Pavla Perlíková; Michal Hocek
Journal:  Med Res Rev       Date:  2017-08-23       Impact factor: 12.944

8.  5-Iodotubercidin inhibits SARS-CoV-2 RNA synthesis.

Authors:  Jianyuan Zhao; Qian Liu; Dongrong Yi; Quanjie Li; SaiSai Guo; Ling Ma; Yongxin Zhang; Dongxin Dong; Fei Guo; Zhenlong Liu; Tao Wei; Xiaoyu Li; Shan Cen
Journal:  Antiviral Res       Date:  2022-01-29       Impact factor: 5.970

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.